During the past decade, Ospedale Santa Croce conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Santa Croce" #1 sponsor was "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 3 trials, followed by "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy" with 1 trials sponsored, "Gruppo Oncologico del Nord-Ovest" with 1 trials sponsored and "Istituti Tumori Giovanni Paolo II" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Croce" #1 collaborator was "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 2 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 2 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "Azienda Ospedaliero, Universitaria Ospedali Riuniti" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Santa Croce" are "Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Adenocarcinoma of the Stomach" (1 trials), "Arrhythmias, Cardiac" (1 trials), "Bladder Cancer" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "Ospedale Santa Croce" in a lesser frequency.

Most popular intervention types in "Ospedale Santa Croce" are "Drug" (10 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (2 trials), "cisplatin" (2 trials), "Bevacizumab" (1 trials), "Bevacizumab and FOLFIRI" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Santa Croce" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Santa Croce". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ospedale Santa Croce, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Santa Croce, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".